SUPPRESSION OF ALLODYNIA INDUCED BY BONE CANCER Russian patent published in 2023 - IPC A61M5/00 A61K38/48 A61P35/00 

Abstract RU 2791640 C2

FIELD: medicine.

SUBSTANCE: invention relates to oncology and can be used to suppress allodynia induced by bone cancer. The use of the invention relates to a botulinum neurotoxin for suppressing allodynia caused by bone cancer in a patient suffering from bone cancer, where the botulinum neurotoxin is administered at a dose of 10-40 U/kg of the patient.

EFFECT: enhanced suppression of allodynia.

10 cl, 4 dwg, 6 tbl, 3 ex

Similar patents RU2791640C2

Title Year Author Number
THERAPEUTIC FUSION PROTEINS 2012
  • Cheddok Dzhon
  • Kharper Elejn
RU2651492C2
SORTASE-LABELED CLOSTRIDIA NEUROTOXINS 2020
  • Loss, Omar
  • Elliott, Mark
RU2801120C2
FUSION PROTEINS AND METHODS OF TREATMENT, PREVENTION OR ALLEVIATION OF PAIN 2013
  • Dzhejms Piter
  • Foster Kejt
  • Cheddok Dzhon
  • Aoki Rodzher Kej
  • Styuard Lens
  • Frensis Dzhozef
RU2652954C2
CATIONIC NEUROTOXINS 2015
  • Liu, Sai Man
  • Hackett, Gavin Stephen
  • Anderson, Dina Brady
RU2733493C2
RECOMBINANT PROTEIN EXPRESSION IN DOUBLE-STRAND C FORM 2006
  • Shpekht Fol'Ker
RU2412253C2
PEG-YLATED MUTANT TOXIN CLOSTRIDIUM BOTULINUM 2007
  • Frefert Jurgen
  • Shpekht Fol'Ker
RU2426739C2
THERAPEUTIC AND COSMETIC USE OF SEROTYPE E NEUROTOXIN BOTULINUM 2019
  • Pons, Laurent
RU2800604C2
BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION 2015
  • Forssen Erik A.
  • Khyuz Patrik M.
  • Rupp Devid S.
RU2720991C2
LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE 2017
  • Yarstad, Anders
  • Friis, Anna
  • Shtal, Ulf
  • Gurell, Ann
  • Agren, Barbro
  • Edstrom, Emiliya
  • Pikett, Endryu
RU2741497C2
NEUROTOXINS THAT DISPLAY REDUCED BIOLOGICAL ACTIVITY 2010
  • Khofmann Fred
  • Frefert Jurgen
RU2582266C2

RU 2 791 640 C2

Authors

Kalinichev, Mikhail

Favre, Christine

Dates

2023-03-13Published

2019-05-21Filed